CLINICAL_TRIALS
trial_result
· 2025-09-02
Clinical Trial Update: A Study of Abemaciclib in Recurrent Glioblastoma [Phase 2]
Summary
Results from a Phase 2 study of abemaciclib in recurrent glioblastoma have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-09-02